Inventor

Frank Narjes

Inventor
Rome, IT

Overview

24→
Patents
2001–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 24 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations34%
C07DHeterocyclic compounds29%
A61KPreparations for medical, dental or toiletry purposes18%
C07HSugars5%
C07KPeptides5%
Y02ATechnologies for adaptation to climate change5%
C07CAcyclic or carbocyclic compounds2%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
C12NMicroorganisms or enzymes2%
PatentTitleYear
11,034,6542,3-dihydroisoindole-1-carboxamides useful as ROR-gamma modulators202110,988,445Compounds202110,526,286Compounds202010,011,566Compounds20189,573,939'Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases'20179,549,917'Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases'20179,265,773'Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases'20168,232,390'Pentacyclic indole derivatives as antiviral agents'20128,148,349'Nucleoside cyclic phosphoramidates for the treatment of RNA-dependent RNA viral infection'20128,101,595'Antiviral indoles'20128,071,568'Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection'20117,989,438'Therapeutic compounds'20117,973,026'Thienopyrroles as antiviral agents'20117,879,815'Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection'20117,795,250'Indole derivatives as antiviral agents'20107,795,247'Tetracyclic indole derivatives as antiviral agents'20107,781,431'Thienopyrroles as antiviral agents'20107,781,422'Antiviral indoles'20107,767,660'Antiviral indoles'20107,662,809'Tetracyclic indole derivatives as antiviral agents'20107,119,073'Peptides and their use as inhibitors of hepatitis C virus ns3 protease'20067,091,209'Dihydroxypyridmidine carboxylic acids as viral polymerase inhibitors'20066,867,284'Peptide inhibitors of hepatitis C virus NS3 protease'20056,197,536'Methodology to produce, and purify and assay polypeptides with the proteolytic activity of the HCV NS3 protease'2001

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2001–2012Patents assigned to ANGELETTI P IST RICHERCHE BIO (17)· patent assignee history
2001–2010Based in Ariccia, IT· patent location history
2006–2012Based in Rome, IT· patent location history
2006–2011Based in Pomezia, IT· patent location history
2011–2017Patents assigned to NARJES FRANK (7)· patent assignee history
2011–2017Patents assigned to MERCK SHARP & DOHME (6)· patent assignee history
2012–2017Patents assigned to HABERMANN JOERG (5)· patent assignee history
2016–2017Based in Kullavik, SE· patent location history
2018–2021Patents assigned to ASTRAZENECA AB (4)· patent assignee history
2018–2021Based in Molndal, SE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ANGELETTI P IST RICHERCHE BIO172001–2012
NARJES FRANKself72011–2017
MERCK SHARP & DOHME62011–2017
HABERMANN JOERG52012–2017
ASTRAZENECA AB42018–2021
Locations
LocationPatentsSpan
Rome, IT102006–2012
Ariccia, IT42001–2010
Molndal, SE32018–2021
Kullavik, SE32016–2017
Pomezia, IT22006–2011